Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)
Public ClinicalTrials.gov record NCT00806754. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy
Study identification
- NCT ID
- NCT00806754
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 340 participants
Conditions and interventions
Conditions
Interventions
- Ciclesonide nasal spray + Azelastine Drug
- Ciclesonide nasal spray + placebo Azelastine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2006
- Primary completion
- Apr 30, 2007
- Completion
- Jul 31, 2007
- Last update posted
- Nov 22, 2016
2006 – 2007
United States locations
- U.S. sites
- 35
- U.S. states
- 20
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Altana/Nycomed | Encinitas | California | 92024 | — |
| Altana/Nycomed | Los Angeles | California | 90025 | — |
| Altana/Nycomed | Mission Viejo | California | 92691 | — |
| Altana/Nycomed | San Diego | California | 92123 | — |
| Altana/Nycomed | San Jose | California | 95117 | — |
| Altana/Nycomed | Colorado Springs | Colorado | 80907 | — |
| Altana/Nycomed | Denver | Colorado | 80206 | — |
| Altana/Nycomed | Lakewood | Colorado | 80401 | — |
| Altana/Nycomed | Gainesville | Georgia | 30501 | — |
| Altana/Nycomed | Savannah | Georgia | 31406 | — |
| Altana/Nycomed | Stockbridge | Georgia | 30281 | — |
| Altana/Nycomed | Overland Park | Kansas | 66210 | — |
| Altana/Nycomed | Metairie | Louisiana | 70006 | — |
| Altana/Nycomed | Shreveport | Louisiana | 71105 | — |
| Altana/Nycomed | Bethesda | Maryland | 20814 | — |
| Altana/Nycomed | North Dartmouth | Massachusetts | 02747 | — |
| Altana/Nycomed | Novi | Michigan | 48375 | — |
| Altana/Nycomed | Rolla | Missouri | 65401 | — |
| Altana/Nycomed | Papillion | Nebraska | 68046 | — |
| Altana/Nycomed | Skillman | New Jersey | 08558 | — |
| Altana/Nycomed | Raleigh | North Carolina | 27612 | — |
| Altana/Nycomed | Cincinnati | Ohio | 45231 | — |
| Altana/Nycomed | Sylvania | Ohio | 43560 | — |
| Altana/Nycomed | Ashland | Oregon | 97520 | — |
| Altana/Nycomed | Medford | Oregon | 97504 | — |
| Altana/Nycomed | Portland | Oregon | 97213 | — |
| Altana/Nycomed | Pittsburgh | Pennsylvania | 15241 | — |
| Altana/Nycomed | Upland | Pennsylvania | 19013 | — |
| Altana/Nycomed | Charleston | South Carolina | 29414 | — |
| Altana/Nycomed | Dallas | Texas | 75231 | — |
| Altana/Nycomed | San Antonio | Texas | 78229 | — |
| Altana/Nycomed | South Burlington | Vermont | 05403 | — |
| Altana/Nycomed | Newport News | Virginia | 23606 | — |
| Altana/Nycomed | Richmond | Virginia | 23226 | — |
| Altana/Nycomed | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00806754, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 22, 2016 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00806754 live on ClinicalTrials.gov.